Leber's Hereditary Optic Neuropathy (LHON) Clinical Trial
Official title:
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy and safety of Raxone® in the long-term treatment of LHON patients.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771379 -
Post Authorisation Safety Study With Raxone in LHON Patients
|
||
Completed |
NCT02796274 -
Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)
|
||
Recruiting |
NCT04912843 -
Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy
|
Phase 2/Phase 3 | |
Terminated |
NCT01389817 -
Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)
|
Phase 1/Phase 2 | |
Completed |
NCT05555784 -
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection
|